## EQIX: Equinix, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_10 -5.7% below STRENGTH zone (3.0-6.0%); PEG 2.90 fails VALUE criteria (<1.0); RSI 27 oversold (REVERSION excluded per A/B test). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($691.32)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. HALPER SADEH LLC ENCOURAGES EQUINIX, INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS**
- Source: Morningstar | 20251130T202900 | Neutral | Relevance: 99%
-  Halper Sadeh LLC, an investor rights law firm, is investigating potential breaches of fiduciary duties by certain officers and directors of Equinix, Inc. The firm encourages Equinix (NASDAQ: EQIX) shareholders to contact them to discuss their rights, which may include seeking corporate governance reforms or financial relief. Shareholder involvement is highlighted as a way to improve company policies and enhance shareholder value.

**2. Bronstein, Gewirtz & Grossman, LLC Is Investigating Equinix, Inc. (EQIX) And Encourages Stockholders to Connect**
- Source: ABC4 Utah | 20251202T110000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. (NASDAQ:EQIX) securities. The investigation focuses on whether Equinix and its officers or directors engaged in corporate wrongdoing, particularly for investors who purchased securities prior to May 3, 2019, and continue to hold them. The law firm is encouraging affected stockholders to connect with them for additional information and to assist in the investigation.

**3. How Is Equinixâ€™s Stock Performance Compared to Other REITs?**
- Source: Barchart.com | 20251201T140646 | Somewhat-Bullish | Relevance: 99%
- Equinix Inc. (EQIX), a leading digital infrastructure provider, has underperformed the broader REIT market, as represented by the Schwab U.S. REIT ETF (SCHH), over the past three months, six months, and 52 weeks despite strong Q3 2025 results. Concerns about rising data center capital expenditures have weighed on the stock, which is down 4.2% over the past three months and 23.1% over the past year. However, Wall Street analysts maintain a "Strong Buy" consensus rating with significant upside potential.

**4. Equinix, Inc. (EQIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation**
- Source: FOX40 News | 20251130T110000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Equinix, Inc. (EQIX) securities who bought before May 3, 2019, and still hold them. The investigation focuses on whether Equinix officers and/or directors engaged in corporate wrongdoing. Stockholders are encouraged to contact the law firm for more information and to assist in the investigation.

**5. Equinix, Inc. (EQIX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation**
- Source: MyStateline | 20251130T160000 | Neutral | Relevance: 99%
- Bronstein, Gewirtz & Grossman, LLC has launched an investigation into potential corporate wrongdoing by Equinix, Inc. (EQIX). The firm is encouraging stockholders who purchased Equinix securities prior to May 3, 2019, and continue to hold them, to contact them to assist with the investigation. This law firm specializes in securities fraud class actions and shareholder derivative suits, representing investors on a contingency fee basis.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 1, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-03 | BMO Capital | $900 | $900 | 0% |
| 2025-11-18 | Truist Securiti | $973 | $961 | +1% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-03 | BMO Capital | up | Outperform |
| 2025-11-18 | Truist Securiti | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 3 ($0.00M) |
| Sells | 10 ($0.35M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 49.3% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 3 |

**Top Holders:**
- Vanguard Group Inc: 13.5% (+1.2%)
- Blackrock Inc.: 11.0% (-1.1%)
- State Street Corpora: 6.4% (+0.2%)
- JPMORGAN CHASE & CO: 5.9% (+151.6%)
- FMR, LLC: 2.7% (+12.7%)

### Key Risks

1. Premium valuation (P/E 48x, PEG 2.9x) vulnerable to multiple compression.
2. Long-term trend broken: trading 11.2% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 2.90 signals overvaluation risk, limited margin of safety. Forward P/E 47.8x stretched relative to 1% growth. Institutional flow bullish (7 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $72.1B |
| Beta | 1.04 |
| 52W Range | $701.41 - $986.50 |
| Short Interest | 1.9% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.90 |
| Forward P/E | 47.8 |
| Current P/E | 48.2 |
| YoY Growth | 0.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from -4.2% to -5.7% (-1.5% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.7pp (needs >3.0% for momentum thesis). Underperforming sector by 3.8pp, stock-specific weakness. Below SMA200 (0.89x), long-term trend not supportive. MACD histogram bearish (-5.69), momentum weakening. RSI oversold at 27, potential bounce setup.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | -5.66% (CS: 3) | Weak |
| RSI_14 | 27.2 | Oversold |
| MACD Histogram | -5.69 | Bearish |
| vs SMA20 | 0.931x | Below |
| vs SMA50 | 0.912x | Below |
| vs SMA200 | 0.888x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $727.38
- **Stop Loss:** $691.32 (5.0% risk)
- **Target:** $763.44 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 13
- **Position Value:** $9,455.94
- **Portfolio %:** 9.46%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate improvement trajectory. VIX compression from 20.5 to 16.6 over 5 days signals declining fear, while 47% breadth shows narrow but recovering participation. Fed meeting in 6 days creates near-term uncertainty, but AI sector momentum and improving technical setups support selective positioning.*

### Earnings

**Next:** 2026-02-11 (Est: $3.61)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $3.43 | $3.89 | +13.1% |
| 2025Q2 | $3.44 | $3.79 | +10.3% |
| 2025Q1 | $2.97 | $3.59 | +20.8% |
| 2024Q4 | $2.74 | $2.97 | +8.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_10*